The MVA Society is a patient advocacy group established as a focal point for the ultra-rare genetic condition Mosaic Variegated Aneuploidy syndrome. The aims of the MVA Society are to act as a patient advocacy support and information resource, build a community of practise and patient cohort, and investigate research into screening, surveillance and treatment of MVA.

At Tanner Pharma Group, we partner with companies to provide access to their medicines in countries where they are not commercially accessible, either because a marketing authorization has not been granted or patients do not have the financial means to pay for them. Our TannerMAP division specializes in designing and delivering named patient supply, US expanded access, compassionate use, early access, managed access, post-trial supply, product withdrawal, and global donation programs.